Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Aug 11, 2022, after the close
10-Q filed Aug 11, 2022, 42 days after period end · 0000950170-22-016942
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $3.86M | $1.41M | $281.00K | $203.00K |
| Net Income | -$3.78M | -$5.26M | -$9.69M | $4.24M |
| EPS Diluted |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$6.81 |
| -$0.24 |
| -$1.04 |
| $0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.